Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Kopp, L. Pesce, J. Solís-S (2008)
Pendred syndrome and iodide transport in the thyroidTrends in Endocrinology & Metabolism, 19
O. Dohán, A. Vieja, V. Paroder, C. Riedel, M. Artani, Mia Reed, C. Ginter, N. Carrasco (2003)
The sodium/iodide Symporter (NIS): characterization, regulation, and medical significance.Endocrine reviews, 24 1
C. Schmutzler, R. Winzer, J. Meissner‐Weigl, J. Köhrle (1997)
Retinoic acid increases sodium/iodide symporter mRNA levels in human thyroid cancer cell lines and suppresses expression of functional symporter in nontransformed FRTL-5 rat thyroid cells.Biochemical and biophysical research communications, 240 3
F. Ambesi-Impiombato, L. Parks, H. Coon (1980)
Culture of hormone-dependent functional epithelial cells from rat thyroids.Proceedings of the National Academy of Sciences of the United States of America, 77 6
David Wiesenfeld, G. Webster, F. Cameron, M. Ferguson, E. Macfadyen, T. Macfarlane (1983)
Salivary gland dysfunction following radioactive iodine therapy.Oral surgery, oral medicine, and oral pathology, 55 2
June-Key Chung (2002)
Sodium iodide symporter: its role in nuclear medicine.Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 43 9
T. Schulte, L. Neckers (1998)
The benzoquinone ansamycin 17-allylamino-17-demethoxygeldanamycin binds to HSP90 and shares important biologic activities with geldanamycinCancer Chemotherapy and Pharmacology, 42
G. Niu, Xiaoyuan Chen (2009)
From protein-protein interaction to therapy response: molecular imaging of heat shock proteins.European journal of radiology, 70 2
N. Fortunati, M. Catalano, Katia Arena, E. Brignardello, A. Piovesan, G. Boccuzzi (2004)
Valproic acid induces the expression of the Na+/I- symporter and iodine uptake in poorly differentiated thyroid cancer cells.The Journal of clinical endocrinology and metabolism, 89 2
T. Kogai, Y. Kanamoto, Lisa Che, K. Taki, F. Moatamed, J. Schultz, G. Brent (2004)
Systemic Retinoic Acid Treatment Induces Sodium/Iodide Symporter Expression and Radioiodide Uptake in Mouse Breast Cancer ModelsCancer Research, 64
H. Shimura, K. Haraguchi, A. Miyazaki, T. Endo, T. Onaya (1997)
Iodide uptake and experimental 131I therapy in transplanted undifferentiated thyroid cancer cells expressing the Na+/I- symporter gene.Endocrinology, 138 10
D. Marsee, Anjli Venkateswaran, Haiyang Tao, D. Vadysirisack, Zhaoxia Zhang, D. Vandré, S. Jhiang (2004)
Inhibition of Heat Shock Protein 90, a Novel RET/PTC1-associated Protein, Increases Radioiodide Accumulation in Thyroid Cells*Journal of Biological Chemistry, 279
R. Elisei, A. Vivaldi, R. Ciampi, P. Faviana, F. Basolo, F. Santini, C. Traino, F. Pacini, A. Pinchera (2006)
Treatment with drugs able to reduce iodine efflux significantly increases the intracellular retention time in thyroid cancer cells stably transfected with sodium iodide symporter complementary deoxyribonucleic acid.The Journal of clinical endocrinology and metabolism, 91 6
T. Kogai, K. Taki, G. Brent (2006)
Enhancement of sodium/iodide symporter expression in thyroid and breast cancer.Endocrine-related cancer, 13 3
L. Lacroix, T. Pourcher, C. Magnon, N. Bellon, M. Talbot, Tosak Intaraphairot, B. Caillou, M. Schlumberger, J. Bidart (2004)
Expression of the apical iodide transporter in human thyroid tissues: a comparison study with other iodide transporters.The Journal of clinical endocrinology and metabolism, 89 3
FS Ambesi, LA Parks, HG Coon (1980)
Culture of hormone-dependent functional epithelial cells from rat thyroidsCell Biol., 77
D. Solit, F. Zheng, M. Drobnjak, P. Münster, B. Higgins, D. Verbel, G. Heller, W. Tong, C. Cordon-Cardo, D. Agus, H. Scher, N. Rosen (2002)
17-Allylamino-17-demethoxygeldanamycin induces the degradation of androgen receptor and HER-2/neu and inhibits the growth of prostate cancer xenografts.Clinical cancer research : an official journal of the American Association for Cancer Research, 8 5
G. Upadhyay, Rajesh Singh, G. Agarwal, S. Mishra, Lily Pal, P. Pradhan, B. Das, M. Godbole (2004)
Functional Expression of Sodium Iodide Symporter (NIS) in Human Breast Cancer TissueBreast Cancer Research and Treatment, 77
G. Dai, O. Levy, N. Carrasco (1996)
Cloning and characterization of the thyroid iodide transporterNature, 379
B. Zsebik, A. Citri, J. Isola, Y. Yarden, J. Szöllősi, G. Vereb (2006)
Hsp90 inhibitor 17-AAG reduces ErbB2 levels and inhibits proliferation of the trastuzumab resistant breast tumor cell line JIMT-1.Immunology letters, 104 1-2
K. Bisht, C. Bradbury, D. Mattson, A. Kaushal, A. Sowers, S. Markovina, Karen Ortiz, Leah Sieck, J. Isaacs, M. Brechbiel, James Mitchell, L. Neckers, D. Gius (2003)
Geldanamycin and 17-allylamino-17-demethoxygeldanamycin potentiate the in vitro and in vivo radiation response of cervical tumor cells via the heat shock protein 90-mediated intracellular signaling and cytotoxicity.Cancer research, 63 24
Schlumberger Martin, Tubiana Maurice, F. Vathaire, Hill Catherine, P. Gardet, J. Travagli, P. Fragu, J. Lumbroso, B. Caillou, C. Parmentier (1986)
Long-term results of treatment of 283 patients with lung and bone metastases from differentiated thyroid carcinoma.The Journal of clinical endocrinology and metabolism, 63 4
T. Kogai, Saima Sajid-Crockett, Lynell Newmarch, Yan-Yun Liu, G. Brent (2008)
Phosphoinositide-3-kinase inhibition induces sodium/iodide symporter expression in rat thyroid cells and human papillary thyroid cancer cells.The Journal of endocrinology, 199 2
L. Neckers (2002)
Hsp90 inhibitors as novel cancer chemotherapeutic agents.Trends in molecular medicine, 8 4 Suppl
O. Clark (1982)
Total thyroidectomy: The Treatment of Choice for patients With Differentiated Thyroid CancerAnnals of Surgery, 196
R. Temple, M. Berman, J. Robbins, J. Wolff (1972)
The use of lithium in the treatment of thyrotoxicosis.The Journal of clinical investigation, 51 10
R. Elisei, Aldo Pinchera, C. Romei, M. Gryczyńska, Viviane Pohl, C. Maenhaut, Laura Fugazzola, F. Pacini (1994)
Expression of thyrotropin receptor (TSH-R), thyroglobulin, thyroperoxidase, and calcitonin messenger ribonucleic acids in thyroid carcinomas: evidence of TSH-R gene transcript in medullary histotype.The Journal of clinical endocrinology and metabolism, 78 4
V. Paroder, S. Spencer, Monika Paroder, D. Arango, S. Schwartz, J. Mariadason, L. Augenlicht, S. Eskandari, N. Carrasco (2006)
Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT.Proceedings of the National Academy of Sciences of the United States of America, 103 19
A. Rodriguez, Barbara Perron, L. Lacroix, B. Caillou, G. Leblanc, M. Schlumberger, J. Bidart, T. Pourcher (2002)
Identification and characterization of a putative human iodide transporter located at the apical membrane of thyrocytes.The Journal of clinical endocrinology and metabolism, 87 7
A. Bizhanova, P. Kopp (2011)
Controversies Concerning the Role of Pendrin as an Apical Iodide Transporter in Thyroid Follicular CellsCellular Physiology and Biochemistry, 28
Hwan-Jeong Jeong, Yuri Kim, Kinam Kim, J. Choe, June-Key Chung, Meyoung-kon Kim (2006)
Effect of all-trans retinoic acid on sodium/iodide symporter expression, radioiodine uptake and gene expression profiles in a human anaplastic thyroid carcinoma cell line.Nuclear medicine and biology, 33 7
S. Usmani, R. Bona, Zihai Li (2009)
17 AAG for HSP90 inhibition in cancer--from bench to bedside.Current molecular medicine, 9 5
Franco Arturi, Diego Russo, Jean-Michel Bidart, D. Scarpelli, Martin Schlumberger, S. Filetti (2001)
Expression pattern of the pendrin and sodium/iodide symporter genes in human thyroid carcinoma cell lines and human thyroid tumors.European journal of endocrinology, 145 2
June-Key Chung, Hyewon Youn, J. Kang, Ho Lee, K. Kang (2010)
Sodium Iodide Symporter and the Radioiodine Treatment of Thyroid CarcinomaNuclear Medicine and Molecular Imaging, 44
Nucl Med Mol Imaging (2012) 46:239–246 DOI 10.1007/s13139-012-0158-4 ORIGINAL ARTICLE The Effect of Tanespimycin (17-AAG) on Radioiodine Accumulation in Sodium-Iodide Symporter Expressing Cells Kyoung Hyun Yu & Hyewon Youn & Myung Geun Song & Dong Soo Lee & June-Key Chung Received: 17 September 2011 /Revised: 4 May 2012 /Accepted: 15 July 2012 /Published online: 15 August 2012 # Korean Society of Nuclear Medicine 2012 Abstract levels of NIS mRNA after tanespimycin treatment was an Purpose The heat shock protein 90 inhibitor, tanespimycin, is observed increase in the hNIS-ARO cells. an anticancer agent known to increase iodine accumulation in Conclusions These results indicate that cellular responses normal and cancerous thyroid cells. Iodine accumulation is against tanespimycin treatment differed between the normal regulated by membrane proteins such as sodium iodide sym- rat thyroid cells and human cancer cells, and the reduction in porter (NIS) and pendrin (PDS), and thus we attempted to the I efflux rate by tanespimycin in the normal rat thyroid characterize the effects of tanespimycin on those genes. cells might be attributable to reduced PDS gene expression. Methods Cells were incubated with tanespimycin in order to . . evaluate I accumulation and efflux ability. Radioiodine Keywords Thyroid cancer
Nuclear Medicine and Molecular Imaging – Springer Journals
Published: Aug 15, 2012
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.